EDIT Editas Medicine, Inc.

EDIT Editas Medicine, Inc.

Healthcare · Biotechnology

Desk view

Watchinglow conviction
Basis Logged decision
Updated

Market read

Scan convergence 1 scan as of 2026-10-16 1 bear converging

POC $2.72 · VWAP $2.77 · -15.2% vs 12m avg buyer

collapse vol: normalchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Cluster CEO, CFO + 1 other sold $19.1K, Sep 4

Coverage

2 watchlists

Watchlists @biotech-scan@ibb

EDIT Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist EDIT belongs to, members best 30-day change first — EDIT highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@ibb
@biotech-scan

Next earnings EDIT reports in 23 days Nov 9

Last report Aug 5

Reported EPS $-0.15 versus analyst consensus of $-0.28 (+46.2%).

full note →

Against street estimates

How EDIT's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 10 quarters · newest report Aug 5 · projection Oct 16

Result
Aug 5 -0.28-0.15+46.2%Beat
May 5 -0.24-0.26-7.6%Miss
Mar 9 -0.21-0.06+72.1%Beat
Nov 10 '25 -0.38-0.28+27.2%Beat
Aug 12 '25 -0.38-0.32 GAAP ≠ +15.3%Beat
May 12 '25 -0.59-0.92-54.9%Miss
Mar 5 '25 -0.33-0.55-67.4%Miss
Nov 4 '24 -0.77-0.75+2.5%Beat

Recent news

Headlines about EDIT from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 1 day ago · Oct 16

Types
Aug 5 Catalyst EDIT earnings
May 5 Catalyst EDIT earnings